A Case of Perioral Dermatitis Successfully Treated with Abrocitinib

Perioral dermatitis (POD) is a chronic inflammatory skin disease that primarily affects females between the ages of 16 and 45. Conventional therapies face the challenge of limited efficacy and a high recurrence rate. In this report, we present the case of a 26-year-old male patient with POD who was...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Yan, Ren, Mingyang, Ding, Yang, Yang, Xianhong, Fan, Yibin, Tao, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612496/
https://www.ncbi.nlm.nih.gov/pubmed/37901150
http://dx.doi.org/10.2147/CCID.S433561
Descripción
Sumario:Perioral dermatitis (POD) is a chronic inflammatory skin disease that primarily affects females between the ages of 16 and 45. Conventional therapies face the challenge of limited efficacy and a high recurrence rate. In this report, we present the case of a 26-year-old male patient with POD who was successfully treated using the Janus kinase (JAK) inhibitor, abrocitinib. This treatment exhibited both good efficacy and safety. Abrocitinib, as a JAK inhibitor, holds promise as a potential therapy for cases of POD that might be resistant to conventional therapies.

Ejemplares similares